324 related articles for article (PubMed ID: 8678512)
1. [Progress of adjuvant chemotherapy in colon cancer].
Toge T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
3. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
4. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
[TBL] [Abstract][Full Text] [Related]
5. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
Kodaira S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
[TBL] [Abstract][Full Text] [Related]
6. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant therapy in colorectal cancer.
Hesketh PJ; Bulger KN
Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant treatment of colonic carcinoma].
Rochlitz CF; Herrmann R
Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
[TBL] [Abstract][Full Text] [Related]
10. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
11. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
Scheithauer W
Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
[TBL] [Abstract][Full Text] [Related]
12. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
13. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
14. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant chemotherapy of colorectal carcinoma].
Casali P; Licitra L; Alafaci E; Gennari L
Ann Ital Chir; 1990; 61(5):509-13. PubMed ID: 2100969
[TBL] [Abstract][Full Text] [Related]
16. Clinical overview: adjuvant therapy of gastrointestinal cancer.
Macdonald JS
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
[TBL] [Abstract][Full Text] [Related]
17. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant therapeutic possibilities in carcinoma of colon and rectum].
Steinke B
Schweiz Rundsch Med Prax; 1992 Jun; 81(26):853-5. PubMed ID: 1626159
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
